Home
Portfolio
Strategy
Team
News
Contact
Investor Login
Home
Portfolio
Strategy
Team
News
Contact
IDEAYA Announces Dosing of First Patient of MAT2A Inhibitor IDE397 in Phase 1 Clinical Trial Evaluating MTAP-Deletion Solid Tumors
Read Article
News
2021
2020
Archive
April 15, 2021
IDEAYA Announces Dosing of First Patient of MAT2A Inhibitor IDE397 in Phase 1 Clinical Trial Evaluating MTAP-Deletion Solid Tumors
April 15, 2021
Scientist.com Recognized as One of The America’s Fastest Growing Companies by The Financial Times
April 14, 2021
Marvin, Halio Inc. Announce Exclusive Agreement to Bring Halio® Smart Glass to Residential Market
April 13, 2021
Kinestral Technologies, Inc. Announces Widely-Recognized Halio Product Name as New Corporate Identity
April 13, 2021
Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss
April 12, 2021
New Study, with Pear Therapeutics, to Identify Best Practices for Implementation in Primary Care of Digital Treatment for Substance Use Disorders
April 9, 2021
Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
April 7, 2021
Homology Medicines Announces Pricing of Public Offering of Common Stock
April 6, 2021
Homology Medicines Announces Proposed Public Offering of Common Stock
April 6, 2021
Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and Senor-Based Technologies
1
2
3
…
6
Next Page »
